{"data":{"id":"us-il/410-ilcs-720-15","jurisdiction":"us-il","citation":"410 ILCS 720/15","heading":"Participation in a drug take-back program.","body":"Each covered manufacturer must, beginning January 1, 2024 or 6 months after becoming a covered manufacturer, whichever is later, individually or collectively implement an approved drug take-back program that complies with the requirements of this Act. A covered manufacturer must establish, fund, and implement a drug take-back program independently or as part of a group of covered manufacturers.","path":["CHAPTER 410 PUBLIC HEALTH","Drug Take-Back Act"],"source_url":"https://www.ilga.gov/legislation/ILCS/details?ActID=4321\u0026ChapterID=35\u0026ChapAct=FullText\u0026Print=True","current_through":"at least Public Act 104-790","vintage":"","retrieved_at":"2026-09-15T04:46:36Z","sha256":"591a0431a00ece6542f26dc9304718e56c85fd1991d249d97a61f735706bf357","source_id":"us-il","stale":false,"prev":"us-il/410-ilcs-720-10","next":"us-il/410-ilcs-720-20"},"notice":"GroundRules: Original legal text. Not legal advice."}